Enlivex (ENLV) Selling, General & Administrative (2013 - 2026)
Enlivex (ENLV) reported Selling, General & Administrative of $1.31 million for Q2 2026, up 39.8% from $937,000 a year earlier.
Powered by 
Analysis
Enlivex (ENLV) Selling, General & Administrative (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Enlivex's Selling, General & Administrative came in at $6.15 million, up 30.2% year-over-year; for FY2025, it was $5.8 million, up 18.0% from FY2024.
- Selling, General & Administrative has a five-year compound annual growth rate of 9.4% (FY2020 to FY2025).
- By year, Selling, General & Administrative came in at $4.91 million in FY2024 (-20.0%), $6.14 million in FY2023 (-13.6%), $7.1 million in FY2022 (+10.9%) and $6.41 million in FY2021 (+73.2%).
- Five-year quarterly Selling, General & Administrative spans a low of $771,000 in Q3 2024 and a high of $2.83 million in Q4 2025.
- Year over year, Selling, General & Administrative gained in four of the last seven quarters, with growth averaging 12.1%.
- The high point for year-over-year Selling, General & Administrative in five years was Q4 2021 (growth of 111.3%); the low point was Q3 2024 (a decline of 39.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Enlivex | 1.19 Mn | -55.21 Mn | - | 1.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.31 Mn |
| Dec 31, 2025 | 2.83 Mn |
| Sep 30, 2025 | 1.07 Mn |
| Jun 30, 2025 | 937,000.00 |
| Mar 31, 2025 | 954,000.00 |
| Dec 31, 2024 | 2.06 Mn |
| Sep 30, 2024 | 771,000.00 |
| Jun 30, 2024 | 987,000.00 |
| Mar 31, 2024 | 1.09 Mn |
| Dec 31, 2023 | 1.64 Mn |
| Sep 30, 2023 | 1.28 Mn |
| Jun 30, 2023 | 1.61 Mn |
| Mar 31, 2023 | 1.61 Mn |
| Dec 31, 2022 | 2.15 Mn |
| Sep 30, 2022 | 1.48 Mn |
| Jun 30, 2022 | 1.76 Mn |
| Mar 31, 2022 | 1.72 Mn |
| Dec 31, 2021 | 2.65 Mn |
| Sep 30, 2021 | 1.19 Mn |
| Jun 30, 2021 | 1.27 Mn |
API Access
Enlivex Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ENLV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "ENLV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ENLV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();